The news comes after another impressive year for Relation, with strong year-over-year revenue and EBITDA growth as the company continues to expand organically and through strategic acquisition.
Relation announces strategic collaboration with Novartis to advance therapeutics for atopic diseases
LONDON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Relation today announced a multi-program, strategic collaboration with Novartis to discover and advance novel targets for atopic diseases. Under the terms of ...
CHICAGO, January 22, 2026--(BUSINESS WIRE)--Relation Insurance Services ("Relation") announced today their acquisition of the assets of PT Business Solutions. The transaction went into effect on ...
Relation and Novartis collaborate to advance treatments for atopic diseases using AI and immuno-dermatology expertise. Relation receives $55 million upfront, with potential milestones up to $1.7 ...
WALNUT CREEK, Calif.--(BUSINESS WIRE)--Relation Insurance Services (“Relation”), one of the largest and fastest-growing national insurance agencies, announced today it acquired the assets of Dallas, ...
CHICAGO--(BUSINESS WIRE)--Relation Insurance Services (“Relation”) acquired the assets of Advantage Insurance Group. The transaction went into effect on May 31, 2025; terms of the transaction were not ...
In its second major partnership with a big pharma group, UK-based AI and multi-omics company Relation Therapeutics has agreed to seek out targets for allergic diseases on behalf of Novartis. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results